Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $385
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga